Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dustin S Sjuts Insider Profile
4 Followers
Dustin S Sjuts, President at Revance Therapeutics, holds 167.55K shares in Revance Therapeutics (Ticker: RVNC). Most recently, Dustin S Sjuts Sold $12,178 shares of Revance Therapeutics on Mar 19, 2024 for an estimated value of 62.15K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+51.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
President
Roles that Dustin S Sjuts holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 16, 2023 - May 16, 2024
Return:+90.50%
The most profitable trade made by Dustin S Sjuts
Dustin S Sjuts's Trading History
List of latest transactions for each holding click on a transaction to see Dustin S Sjuts's performance on stock
You May Also Like
Dustin S Sjuts insider profile FAQ
What is the percentage of profitable transactions made by Dustin S Sjuts?
The percentage of profitable transactions made by Dustin S Sjuts is 67%.
What is the average return per transaction made by Dustin S Sjuts?
The average return per transaction made by Dustin S Sjuts is 51.10%.
What stocks does Dustin S Sjuts hold?
Dustin S Sjuts holds: RVNC stocks.
What was Dustin S Sjuts’s latest transaction?
Dustin S Sjuts latest transaction was an Informative Sell of $62.15K.
What was Dustin S Sjuts's most profitable transaction?
Dustin S Sjuts’s most profitable transaction was an Informative Sell of RVNC stock on May 16, 2023. The return on the trade was 90.50%.
What is Dustin S Sjuts's role in Revance Therapeutics?
Dustin S Sjuts's role in Revance Therapeutics is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.